Skip to NavigationSkip to content

Dr Steven Leventer to head up neuroscience research for PharmaNet

Published on: 17/02/10

PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research - neuroscience.

Leventer joins PharmaNet from Wyeth (now part of Pfizer) and was formerly vice president for central nervous system development at Quintiles.

"We are very pleased to have Steve join PharmaNet Development Group," commented Dalvir Gill, chief operating officer of late stage development.

"Steve is a recognised expert in the fields of clinical trial design and clinical development planning. His combination of neuroscience expertise and dedication to efficiency and quality provides the right complement to our existing organisation."

Dr Leventer has over twenty years of experience in all phases of drug development. He has spent most of his career leading clinical teams at large global pharmaceutical and contract research organisations in the development of therapeutics for Alzheimer’s disease, schizophrenia, depression and other central nervous system diseases.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches